Skip to main content
    O

    Oruka Therapeutics, Inc. (ORKA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $73.87
    -2.81 (-3.66%)

    Market Cap: $5.08B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(15/23)
    Avg Surprise
    -129.49%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.62
    Range$-0.79 - $-0.41
    9 analysts
    EPS RevisionsNo revisions (7d)
    1
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.51-22.0%
    60d ago$-0.51-22.0%
    30d ago$-0.620.0%
    7d ago$-0.620.0%
    Current$-0.62
    Revenue Consensus
    $0
    Range$0 - $0
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.70
    Range$-1.24 - $-0.17
    9 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.70---
    Sep 26EST
    		-$-0.62---
    Jun 26
    Reported Aug 10
    		$-0.55$-0.49-12.24%Miss-19.6%
    Mar 26
    Reported May 13
    		$-0.48$-0.54+11.11%Beat-20.0%
    Dec 25
    Reported Mar 12
    		$-0.45$-0.62+26.90%Beat+16.7%
    Sep 25
    Reported Nov 12
    		$-0.55$-0.52-5.77%Miss+62.3%
    Jun 25
    Reported Aug 11
    		$-0.46$-0.43-6.98%Miss+79.2%
    Mar 25
    Reported May 14
    		$-0.40$-0.44+9.09%Beat-185.7%
    Dec 24
    Reported Mar 6
    		$-0.54$-0.41-31.71%Miss+40.1%
    Sep 24
    Reported Nov 13
    		$-1.46$-0.32-356.25%Miss-23.1%
    Jun 24
    Reported Aug 27
    		$-2.22N/AN/ABeat-79.7%
    Mar 24
    Reported Apr 25
    		$-0.14N/AN/ABeat-55.6%
    Dec 23
    Reported Feb 1
    		$-0.90N/AN/ABeat-1026.5%
    Sep 23
    Reported Nov 7
    		$-1.19N/AN/ABeat-641.1%
    Jun 23
    Reported Jul 21
    		$-1.23N/AN/ABeat-460.2%
    Mar 23
    Reported Jun 29
    		$-0.09N/AN/ABeat+83.6%
    Dec 22
    Reported Mar 30
    		$-0.08N/AN/ABeat+85.5%
    Sep 22
    Reported Oct 28
    		$-0.16N/AN/ABeat+51.5%
    Jun 22
    Reported Aug 2
    		$-0.22N/AN/ABeat+35.3%
    Mar 22
    Reported Jun 29
    		$-0.55N/AN/ABeat-66.7%
    Dec 21
    Reported Mar 30
    		$-0.55N/A+75.45%Beat+0.0%
    Sep 21
    Reported Nov 2
    		$-0.33N/A+85.65%Beat+0.0%
    Jun 21
    Reported Aug 4
    		$-0.34N/A+85.65%Beat+53.4%
    Mar 21
    Reported Jun 29
    		$-0.33N/A+82.35%Beat+60.2%
    Dec 20
    Reported Mar 30
    		$-0.55N/A+77.46%Beat-41.0%
    Sep 20
    Reported Nov 2
    		$-0.33N/A+86.85%Beat+56.6%
    Jun 20
    Reported Aug 5
    		$-0.73N/A+71.71%Beat+36.0%
    Mar 20
    Reported Jun 29
    		$-0.83N/A+59.31%Beat+55.4%
    Dec 19
    Reported Mar 30
    		$-0.39N/A+60.61%Beat+80.3%
    Sep 19
    Reported Nov 6
    		$-0.76$-1.30+41.54%Beat+61.6%
    Jun 19
    Reported Aug 1
    		$-1.14$-1.86+38.71%Beat+57.8%
    Mar 19
    Reported Jun 29
    		$-1.86$-1.98+6.06%Beat+95.7%
    Dec 18
    Reported Mar 30
    		$-1.98$-0.14-1314.29%Miss+97.4%
    Sep 18
    Reported Nov 14
    		$-1.98$-0.19-942.11%Miss+97.6%
    Jun 18
    Reported Aug 9
    		$-2.70$-0.22-1127.27%Miss+97.9%
    Mar 18
    Reported Jun 29
    		$-43.37N/AN/ABeat+57.9%
    Dec 17
    Reported Mar 30
    		$-76.99N/AN/ABeat+23.7%
    Sep 17
    Reported Nov 10
    		$-83.24N/AN/ABeat-
    Jun 17
    Reported Aug 15
    		$-127.91N/AN/ABeat-
    Mar 17
    Reported Jun 29
    		$-103.03N/AN/ABeat-
    Dec 16
    Reported Mar 30
    		$-100.93N/AN/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00

    Key Metrics

    Valuation
    P/E Ratio-36.39EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-18.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio38.51xQuick Ratio38.51x
    Trading Statistics
    Beta-0.11Avg Volume1.06M
    52-Week High$115.5252-Week Low$25.11

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$79.71
    SMA 20$83.64
    SMA 50$93.10
    SMA 200$66.11
    EMA 10$79.36
    EMA 20$82.90
    EMA 50$87.26
    EMA 200$69.81

    MACD

    Line: -4.40Signal: -3.86Hist: -0.54

    ADX

    ADX: 29.0+DI: 11.5-DI: 30.9

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$83.97

    Bollinger Bands

    Upper Band$95.31
    Lower Band$71.98
    %B Position2788%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    30.2

    Momentum Oscillators

    Stoch %K11.5
    Stoch %D17.4
    Williams %R-94.6
    ROC (10d)-11.4%
    Momentum-9.55
    CCI (20d)-140.3
    MFI (14d)29.7

    Volatility Measures

    ATR (14d)$4.31(5.8%)
    StdDev (20d)5.83
    Hist Vol42.5%(High)

    Volume Flow

    VWAP$74.97
    OBV28.2M
    AD Line-2.3M
    CMF (20d)-0.260

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.2x
    VWMA (20d)$84.63

    Pivot Points

    R3$81.52
    R2$80.05
    R1$78.36
    Pivot Point$76.89
    S1$75.20
    S2$73.73
    S3$72.04

    Advanced Oscillators

    TSI-30.26
    Ultimate Osc40.7
    KST-163.22

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0N/A$0$0$0N/AN/A
    Cost of Revenue$43,000$43,000$28,000N/A$19,000$16,000$16,000$-20,000$12,000$19,000$23,000$30,000
    Gross Profit$-43,000$-43,000$-28,000N/A$-19,000$-16,000$-16,000$20,000$-12,000$-19,000$-23,000$-30,000
    Operating Expenses$50.06M$36.39M$34.40M$34.10M$28.43M$25.09M$38.33M$29.45M$21.49M$2.46M$1.57M$1.91M
    R&D$43.26M$29.14M$27.64M$28.99M$24.09M$19.93M$32.33M$25.69M$18.67M$165,000$47,000$322,000
    SG&A$6.85M$7.29M$6.79M$4.92M$4.34M$5.16M$5.68M$3.66M$2.82M$1.67M$0$0
    Operating Income$-50,107,000$-36,434,000$-34,431,000$-34,105,000$-28,429,000$-25,086,000$-38,329,174$-29,449,000$-21,493,000$-2,482,000$-1,590,000$-1,937,000
    Interest Income$8.90M$4.61M$4.85M$3.83M$3.86M$4.09M$0$1.33M$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$504,000$750,000$214,000$0$0
    Income Before Tax$-41,206,000$-31,820,000$-29,583,000$-30,277,000$-24,574,000$-20,999,000$-33,392,265$-28,623,000$-22,243,000$-2,009,000$-1,089,000$-1,424,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-41,206,000$-31,820,000$-29,583,000$-30,277,000$-24,574,000$-20,999,000$-33,392,265$-28,623,000$-22,243,000$-2,009,000$-1,089,000$-1,424,000
    EBITDA$-50,064,000$-31,777,000$-29,555,000$-30,257,000$-24,555,000$-20,983,000$-37,437,992$-28,119,000$-22,231,000$-1,990,000$-1,066,000$-1,394,000
    EBIT$-50,107,000$-31,820,000$-29,583,000$-30,277,000$-24,574,000$-20,999,000$-37,456,447$-28,099,000$-22,243,000$-2,009,000$-1,089,000$-1,424,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ORKA

    News

    No news available

    Company news will appear here when available

    ORKA Valuation and Fair Value

    P/E
    -36.4x
    P/B
    4.2x
    See GNG's fair value

    ORKA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -18.2%

    ORKA Competitors

    CompanyTicker
    Erasca IncERAS
    Sotera Health CoSHC
    Waystar Holding Corp. Common StockWAY
    PTC Therapeutics IncPTCT
    Mirum Pharmaceuticals IncMIRM
    Travere Therapeutics IncTVTX
    Merit Medical Systems IncMMSI
    Terns Pharmaceuticals IncTERN

    Sector: Healthcare

    ORKA Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    11
    Hold
    0
    Sell
    0
    Strong Sell
    0

    ORKA Bull Case vs Bear Case

    Bull case

    • 100.0% of ORKA's analyst ratings are Buy or Strong Buy.

    Bear case

    • ORKA beat EPS estimates in 37.5% of its last 8 reported quarters.

    ORKA Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -45.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.62
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 7 down

    ORKA Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About ORKA

    Does ORKA pay dividends?

    Oruka Therapeutics, Inc. (ORKA) has a dividend payment track record. See the ORKA dividend history page for its current payment status, TTM yield, and recorded payments.

    What is ORKA's market cap?

    Oruka Therapeutics, Inc. (ORKA) has a market capitalization of $5.08B with a current stock price of $73.87.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In